Workforce strategy
Oncology Talent: Experience Becomes Clear in the Decisions a Professional Can Explain
Use role-specific oncology scenarios to evaluate Senior CRA and CTM judgment, escalation and follow-through.
By Lampgen Clinical Research

3 min read · estimated
What the source reported
FDA’s monitoring guidance emphasizes communicating important findings and acting on them within the study’s oversight framework. [1] Its ICH E6(R3) guidance provides a broader quality and responsibility framework. [2] Neither source validates a particular hiring scorecard, guarantees a candidate’s performance or establishes that years in oncology alone demonstrate readiness for every assignment.
What this means for trial teams
Lampgen’s analysis: an oncology title is an introduction to a candidate, not a complete account of what they can do. Indication experience matters, but the work also depends on phase, treatment modality, site setting, assessment complexity and the decisions attached to the role. A useful evaluation asks for evidence that matches the actual assignment.
For a Senior CRA, explore how the candidate verifies an important site finding. Ask what records they would examine, which questions need clarification, how they would document uncertainty and when they would escalate. A strong answer should make the reasoning visible without implying that the CRA independently makes medical or protocol-governance decisions.
For a Senior CTM, extend the scenario across sites. Ask how the candidate would distinguish a local problem from a possible study-wide pattern, engage the relevant functions and follow an agreed response. Listen for dependencies, authority, timelines and verification. A response that names every stakeholder but never identifies a decision can still leave the problem unresolved.
Use examples candidates can discuss appropriately. They should avoid patient identifiers, confidential sponsor information and proprietary study materials. A generalized account can still explain the situation, the evidence considered, the action within the candidate’s role and the result they can substantiate. Do not equate a compelling story with verified employment or credentials; those require their own appropriate checks.
An illustrative interview exercise could describe a time-sensitive specimen issue repeated at several sites. Give enough information for the candidate to ask sensible questions, while leaving the cause unknown. Ask what they would do first and what would make them change their initial view. This tests judgment without rewarding a memorized answer to an invented root cause.
Define the assignment with equal care. Candidates need to know whether the need concerns monitoring coverage, site relationship management, start-up coordination or study-level oversight. Location, travel, operating model, duration and decision authority matter when a real opportunity is discussed. Do not use unverified vacancies or unspecified client demand to create urgency.
Lampgen invites experienced oncology Senior CRAs and CTMs to express interest through its website’s candidate pathway. Interest in a talent network does not guarantee an assignment. Any specific opportunity should be assessed for fit, with candidate permission obtained before external representation. This invitation does not announce a particular active requisition.
The practical impact is a better fit conversation for both sides. Candidates can prepare examples of defensible decisions; hiring teams can explain the responsibilities they need covered. Lampgen’s focus is connecting oncology clinical-operations requirements with evidence of relevant professional judgment, rather than promising that any staffing process eliminates trial risk.